Triana Biomedicines
58 employees
Biotech/Pharma
Series B · $246.0M
Open positions (2)
Company details
Team Size58
IndustryBiotech/Pharma
Funding
Total raised
$246.0M
Last stage
Series B
Investors
Lightspeed Venture Partners
Total raised
$246.0M
Last stage
Series B
Investors
Jesse Chen
Co-founder and former CTO of Triana Biomedicines; previously with targeted protein degradation firm Kymera Therapeutics.
Milind Deshpande
Founding CEO of Triana Biomedicines and Board Member; previously co-founder and Acting CEO of Hyku.
Simon Read
Co-founder of Triana Biomedicines.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.